Saturday, April 30, 2011

Zytiga Approved for Advanced Prostate Cancer (HealthDay)

Zytiga Approved for Advanced Prostate Cancer
(HealthDay)
: "HealthDay - FRIDAY, April 29 (HealthDay News) -- Zytiga (abiraterone
acetate), used in combination with the steroid prednisone, has been
approved to treat advanced prostate cancer, the U.S. Food and Drug
Administration said in a news release."

The most common adverse reactions to the drug combination included joint discomfort, low blood potassium, fluid retention, muscle discomfort, hot flashes, diarrhea, urinary tract infection, cough, high blood pressure, heartbeat abnormalities, increased urinary frequency, upset stomach and upper respiratory infection.

Tuesday, April 26, 2011

Heart-Healthy Omega-3s Not Healthy for Prostate: Study (HealthDay)

Heart-Healthy Omega-3s Not Healthy for Prostate: Study
(HealthDay)
: "HealthDay - MONDAY, April 25 (HealthDay News) -- High levels of heart-healthy
omega-3 fatty acids in the blood may be associated with an increased risk
for developing aggressive prostate cancer, while elevated levels of
unhealthy trans-fatty acids may lower the risk, a new study suggests."

"Overall, the beneficial effects of eating fish to prevent heart disease outweigh any harm related to prostate cancer risk. "What this study shows is the complexity of nutrition and its impact on disease risk, and that we should study such associations rigorously, rather than make assumptions."

Friday, April 22, 2011

Half of men feel worse after prostate removal

Half of men feel worse after prostate removal: "NEW YORK (Reuters Health) - A new study shows nearly half of men feel worse after having their prostate gland removed due to cancer, although three-quarters would do it again given the same circumstances.

Three out of four had regained their physical and mental well-being and had no more problems with incontinence than before the operation. But just one out of four had recovered his ability to have intercourse.




"

Friday, April 1, 2011

Prostate Cancer Screening Doesn't Cut Death Rates: Study (HealthDay)

Prostate Cancer Screening Doesn't Cut Death Rates: Study
(HealthDay)
: "HealthDay - THURSDAY, March 31 (HealthDay News) -- A 20-year study from
Sweden suggests that screening for prostate cancer does not substantially
reduce the risk of death from the disease."

Wednesday, March 30, 2011

New Therapy for Enlarged Prostate May Bypass Unpleasant Side Effects (HealthDay)

New Therapy for Enlarged Prostate May Bypass Unpleasant Side
Effects
(HealthDay)
: "HealthDay - TUESDAY, March 29 (HealthDay News) -- A minimally invasive
treatment for enlarged prostate that limits blood supply to the prostate
seems to be just as effective as surgery but without the risk of
debilitating side effects, such as impotence and urinary incontinence."

Drugs are used to treat most patients with an enlarged prostate, with only about 10 percent qualifying for surgery to remove the entire gland, said Dr. Elizabeth Kavaler, a urologist at Lenox Hill Hospital in New York City.

"Because medication is so effective, most of the patients that we treat surgically are in pretty bad shape," she added. And while this study showed some symptomatic improvement, it didn't have enough objective data to show that the new technique would surpass surgery, she said.

Too many old men get prostate cancer tests: study

Too many old men get prostate cancer tests: study: "NEW YORK (Reuters Health) - Many men in their 80s get regular blood tests for prostate cancer even though there's no evidence the tests will benefit them, according to a new study.

In older men, finding hidden prostate cancer might not be helpful, because the cancer might not shorten their lifespan. But once it's discovered, a very early-stage cancer usually leads to painful and expensive medical encounters.

So with elderly men, screening "makes no sense," Dr. Peter Albertsen, a prostate cancer researcher at University of Connecticut Health Center in Farmington who was not involved with the current study, told Reuters


Doctors may be used to ordering the prostate cancer blood tests in these men without really thinking about it.




"

Friday, March 25, 2011

Short Course of Hormone Therapy Boosts Prostate Cancer Survival: Study (HealthDay)

Short Course of Hormone Therapy Boosts Prostate Cancer Survival:
Study
(HealthDay)
: "HealthDay - THURSDAY, March 24 (HealthDay News) -- Just six months of hormone
therapy, along with radiation, cuts the risk of dying from locally
advanced prostate cancer in half when compared to radiation alone,
researchers report."